K23 CA109613-A1/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2006	1
2007	2
2008	2
2009	1
2010	5
2011	1
2013	1
2024	0

1

Hypoxia inducible factor-alpha activation in lymphoma and relationship to the thioredoxin family.

Evens AM, Schumacker PT, Helenowski IB, Singh AT, Dokic D, Keswani A, Kordeluk E, Raji A, Winter JN, Jovanovic BD, Holmgren A, Nelson BP, Gordon LI. Evens AM, et al. Br J Haematol. 2008 May;141(5):676-80. doi: 10.1111/j.1365-2141.2008.07093.x. Epub 2008 Apr 15. Br J Haematol. 2008. PMID: 18422776 Free PMC article.

2

A multicenter phase II study incorporating high-dose rituximab and liposomal doxorubicin into the CODOX-M/IVAC regimen for untreated Burkitt's lymphoma.

Evens AM, Carson KR, Kolesar J, Nabhan C, Helenowski I, Islam N, Jovanovic B, Barr PM, Caimi PF, Gregory SA, Gordon LI. Evens AM, et al. Ann Oncol. 2013 Dec;24(12):3076-81. doi: 10.1093/annonc/mdt414. Epub 2013 Oct 20. Ann Oncol. 2013. PMID: 24146219 Free PMC article. Clinical Trial.

3

Mitochondrial-mediated apoptosis in lymphoma cells by the diterpenoid lactone andrographolide, the active component of Andrographis paniculata.

Yang S, Evens AM, Prachand S, Singh AT, Bhalla S, David K, Gordon LI. Yang S, et al. Clin Cancer Res. 2010 Oct 1;16(19):4755-68. doi: 10.1158/1078-0432.CCR-10-0883. Epub 2010 Aug 26. Clin Cancer Res. 2010. PMID: 20798229 Free PMC article.

4

PCI-24781 induces caspase and reactive oxygen species-dependent apoptosis through NF-kappaB mechanisms and is synergistic with bortezomib in lymphoma cells.

Bhalla S, Balasubramanian S, David K, Sirisawad M, Buggy J, Mauro L, Prachand S, Miller R, Gordon LI, Evens AM. Bhalla S, et al. Clin Cancer Res. 2009 May 15;15(10):3354-65. doi: 10.1158/1078-0432.CCR-08-2365. Epub 2009 May 5. Clin Cancer Res. 2009. PMID: 19417023 Free PMC article.

5

Hypoxia-inducible factor-1 {alpha} expression predicts superior survival in patients with diffuse large B-cell lymphoma treated with R-CHOP.

Evens AM, Sehn LH, Farinha P, Nelson BP, Raji A, Lu Y, Brakman A, Parimi V, Winter JN, Schumacker PT, Gascoyne RD, Gordon LI. Evens AM, et al. J Clin Oncol. 2010 Feb 20;28(6):1017-24. doi: 10.1200/JCO.2009.24.1893. Epub 2010 Jan 4. J Clin Oncol. 2010. PMID: 20048181 Free PMC article.

6

Glutathione depletion enhances arsenic trioxide-induced apoptosis in lymphoma cells through mitochondrial-independent mechanisms.

Bhalla S, Gordon LI, David K, Prachand S, Singh AT, Yang S, Winter JN, Guo D, O'Halloran T, Platanias LC, Evens AM. Bhalla S, et al. Br J Haematol. 2010 Aug;150(3):365-9. doi: 10.1111/j.1365-2141.2010.08197.x. Epub 2010 Apr 16. Br J Haematol. 2010. PMID: 20408844 Free PMC article. No abstract available.

7

G-CSF is not necessary to maintain over 99% dose-intensity with ABVD in the treatment of Hodgkin lymphoma: low toxicity and excellent outcomes in a 10-year analysis.

Evens AM, Cilley J, Ortiz T, Gounder M, Hou N, Rademaker A, Miyata S, Catsaros K, Augustyniak C, Bennett CL, Tallman MS, Variakojis D, Winter JN, Gordon LI. Evens AM, et al. Br J Haematol. 2007 Jun;137(6):545-52. doi: 10.1111/j.1365-2141.2007.06598.x. Epub 2007 Apr 24. Br J Haematol. 2007. PMID: 17459049 Free article.

8

A phase II clinical trial of intensive chemotherapy followed by consolidative stem cell transplant: long-term follow-up in newly diagnosed mantle cell lymphoma.

Evens AM, Winter JN, Hou N, Nelson BP, Rademaker A, Patton D, Singhal S, Frankfurt O, Tallman MS, Rosen ST, Mehta J, Gordon LI. Evens AM, et al. Br J Haematol. 2008 Feb;140(4):385-93. doi: 10.1111/j.1365-2141.2007.06908.x. Epub 2007 Dec 19. Br J Haematol. 2008. PMID: 18162124 Free article. Clinical Trial.

9

Multicenter analysis of 80 solid organ transplantation recipients with post-transplantation lymphoproliferative disease: outcomes and prognostic factors in the modern era.

Evens AM, David KA, Helenowski I, Nelson B, Kaufman D, Kircher SM, Gimelfarb A, Hattersley E, Mauro LA, Jovanovic B, Chadburn A, Stiff P, Winter JN, Mehta J, Van Besien K, Gregory S, Gordon LI, Shammo JM, Smith SE, Smith SM. Evens AM, et al. J Clin Oncol. 2010 Feb 20;28(6):1038-46. doi: 10.1200/JCO.2009.25.4961. Epub 2010 Jan 19. J Clin Oncol. 2010. PMID: 20085936 Free PMC article.

10

Rituximab-associated hepatitis B virus (HBV) reactivation in lymphoproliferative diseases: meta-analysis and examination of FDA safety reports.

Evens AM, Jovanovic BD, Su YC, Raisch DW, Ganger D, Belknap SM, Dai MS, Chiu BC, Fintel B, Cheng Y, Chuang SS, Lee MY, Chen TY, Lin SF, Kuo CY. Evens AM, et al. Ann Oncol. 2011 May;22(5):1170-1180. doi: 10.1093/annonc/mdq583. Epub 2010 Nov 29. Ann Oncol. 2011. PMID: 21115603 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Results by year